300 related articles for article (PubMed ID: 16207826)
1. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.
Wenderfer SE; Ke B; Hollmann TJ; Wetsel RA; Lan HY; Braun MC
J Am Soc Nephrol; 2005 Dec; 16(12):3572-82. PubMed ID: 16207826
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
3. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
[TBL] [Abstract][Full Text] [Related]
4. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
Hu N; Long H; Zhao M; Yin H; Lu Q
Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
[TBL] [Abstract][Full Text] [Related]
6. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
8. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
[TBL] [Abstract][Full Text] [Related]
10. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
11. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
[TBL] [Abstract][Full Text] [Related]
12. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
Reilly CM; Olgun S; Goodwin D; Gogal RM; Santo A; Romesburg JW; Ahmed SA; Gilkeson GS
Eur J Immunol; 2006 May; 36(5):1296-308. PubMed ID: 16541466
[TBL] [Abstract][Full Text] [Related]
14. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
[TBL] [Abstract][Full Text] [Related]
15. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
18. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
Chan O; Shlomchik MJ
J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
[TBL] [Abstract][Full Text] [Related]
19. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
Nicoletti F; Di Marco R; Zaccone P; Xiang M; Magro G; Grasso S; Morrone S; Santoni A; Shoenfeld Y; Garotta G; Meroni P
Eur J Immunol; 2000 Feb; 30(2):438-47. PubMed ID: 10671199
[TBL] [Abstract][Full Text] [Related]
20. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
